NCT01885182 2019-10-04
Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain
Mundipharma (China) Pharmaceutical Co. Ltd
Phase 3 Completed
Mundipharma (China) Pharmaceutical Co. Ltd
Mundipharma Research GmbH & Co KG
Mundipharma Korea Ltd
Mundipharma Korea Ltd
Mundipharma Korea Ltd